American Century Companies Inc Atai Life Sciences N.V. Transaction History

American Century Companies Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$1.27 - $2.6 $45,830 - $93,826	-36,087 Reduced 77.39%	10,541 $14,000
Q1 2024 May 14, 2024	BUY	$1.5 - $2.19 $69,942 - $102,115	46,628 New	46,628 $91,000
Q3 2023 Nov 13, 2023	BUY	$1.27 - $2.28 $16,200 - $29,083	12,756 Added 36.54%	47,663 $61,000
Q2 2023 Aug 14, 2023	BUY	$1.44 - $2.19 $15,860 - $24,120	11,014 Added 46.1%	34,907 $60,000
Q1 2023 May 11, 2023	BUY	$1.17 - $2.7 $6,161 - $14,218	5,266 Added 28.27%	23,893 $43,000
Q4 2022 Feb 13, 2023	BUY	$2.38 - $3.55 $44,332 - $66,125	18,627 New	18,627 $49,000

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.